AbbVie to buy leukemia drugmaker Pharmacyclics for $21 billion

On Wednesday, pharmaceutical major AbbVie announced that it has entered into a deal worth $21 billion with cancer biotech Pharmacyclics Inc. AbbVie Inc. will buy Pharmacyclics in a cash and stock deal.

The deal, which would be a mix of cash and stock, would allow AbbVie to have its presence in the multibillion-dollar blood-cancer market. Secondly, the deal would reduce AbbVie's dependence on an aging rheumatoid-arthritis drug, which makes most of its sales.

Last year, AbbVie had an agreement worth $54 billion as per which it would buy Irish drug company Shire PLC. But it walked away after the Obama administration increased the strictness level in order to deter such tax-lowering deals.

Service sector of US speeds up

According to a report of the Institute for Supply Management (ISM), the service sector of the United States economy has sped up in the previous month even there was harsh weather in the east and slowdown of West Coast port.

As per the Wednesday report of the institute, the ISM purchasing managers index increased to about 56.9. A month before, it was 56.7, as per the report. The increase is about three points better than a year ago, but slower than the level of November. That time, it was 58.8, the institute stated. Figure above 50 is considered as an expansion in the sector.

American Eagle Outfitters Stock soars

American Eagle Outfitters (AEO) is among the apparel retailers in the United States who have struggled to drive store traffic over the last few years. On Wednesday, the clothing company reported its fourth quarter performance for fiscal year of 2014. The company has beaten the revenue expectations of analysts.

According to reports, the stock of the company has risen about 7.69% at $15.96 at the closing bell. The soared shares have surprised the market with good earnings in the fourth quarter. The company has posted revenue of about $1.07 billion, which was up by 3%. Earlier, analysts had predicted revenue of about $1.06 billion for the fourth quarter of 2014.

US big banks urge for custom-made approach to Fed stress tests

Many big banks in the United States have been urging the Federal Reserve to modify the methodology used in annual stress tests.

Annual stress tests are used by the Federal Reserve to determine the ability of banks to survive a recession and keep lending after being affected by potential economic shocks, such as a spike in unemployment or a crash in stock market.

The test requires lenders to project losses on various loans and operations using a standard index through which the resiliency of the entire financial system is judged. They were launched in 2011 under the 2010 Dodd-Frank financial reform bill to gauge how much capital banks can use for dividends or stock buybacks.

McDonald’s to Stop Using Chicken raised using certain Antibiotics

Tyson Foods, one of the biggest meat suppliers in the country, is working closely with fast food chain McDonald's to reduce the use of antibiotics in the chicken supplied by the company. McDonald's has asked chicken suppliers to stop using antibiotics that are crucial for human health after reports that the higher use of antibiotics is leading to health issues and stronger infection outbreaks.

McDonald's announced on Wednesday that the company is planning to stop using chicken raised using antibiotics deemed important to human health.

Fed Survey: US Economy growing at Moderate Pace

The Federal Reserve has revealed that despite interruptions caused by extreme winter storms, the US economy has shown a growth at moderate pace through mid-February. The Fed said that out of the 12 regions, six have reported moderate growth with modest gains seen in most other areas. The Boston district reported that the businesses in its area remained up despite several huge snowstorms.

According to the Fed survey, the consumer spending rose in most of the districts, travel and tourism increased, and manufacturing has shown solid gains with San Francisco region's aerospace companies forecasting a record year.

Pages

News in Focus

Nvidia (NVDA) Stock Price Could Reach $300 as per Bernstein’s David Dai; Nasdaq Composite at Record Highs

Nvidia continues to command the narrative in global technology markets, with Bernstein reaffirming its bullish stance and projecting a $300 price target, anchored by the transformative potential o

Nasdaq Composite Closes at All-Time Highs; Nvidia Stock Price Above $200, Tesla Closes 3% Higher

Nasdaq Composite Closed at all-time highs as investors turned bullish on Iran-US talks to end the war.

HDFC AMC Share Price Target at Rs 3,063: Deven Choksey Research

Deven Choksey Research has reiterated an ACCUMULATE stance on HDFC Asset Management Company, highlighting that the recent earnings miss is largely optical and driven by one-off treasury adjustments

ICICI Prudential Life Insurance Share Price Target at Rs 650: Motilal Oswal

Motilal Oswal Financial Services has reiterated a BUY call on ICICI Prudential Life Insurance with a target price of Rs 650, implying an upside of ~19% from the current market pric

Nasdaq Composite Closes at All-Time Highs; Tesla Stock Price Jumps 7.6%, MSFT Stock Gains 4.6

The Nasdaq Composite has surged into record territory, signaling a renewed wave of bullish momentum driven largely by heavyweight technology stocks.